论文信息 - Preventing Preeclampsia by Silencing Soluble Flt‐1? - 字舞流文

Preventing Preeclampsia by Silencing Soluble Flt‐1?

Preventing Preeclampsia Soluble Flt-1 (sFlt-1) is a known mediator of vascular events that cause preeclampsia. A recent study showed that suppressing the synthesis of sFlt-1 in mouse and baboon mod...

[1] M. Moore,et al. RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia. , 2018, Nature Biotechnology.

[2] D. Charnock-Jones,et al. Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia , 2016, Journal of reproductive immunology.

[3] I. Konishi,et al. Case of soluble fms‐like tyrosine kinase 1 apheresis in severe pre‐eclampsia developed at 15 weeks’ gestation , 2015, The journal of obstetrics and gynaecology research.

[4] T. Libermann,et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. , 2003, The Journal of clinical investigation.

[5] J. Scott,et al. IMMUNOLOGY OF PRE-ECLAMPSIA , 1978, The Lancet.